Kidney care giant DaVita has acquired transplant software company MedSleuth to ease access burdens on kidney and liver transplant candidates, Fierce Healtrhcare reports.
MedSleuth’s products won’t be used by DaVita’s providers or at its clinics, which don’t offer transplants. They’ll continue to be used by MedSleuth clients at transplant centers across the country. The acquisition will bolster DaVita’s portfolio of efforts in kidney care, despite not integrating directly with its primary business.
The company declined to disclose the financial terms of the deal. Read more.
